Evidence map›Paper›PMID 34717565›Full record

ArticleBMC infectious diseases2021

Norovirus GII.2[P16] strain in Shenzhen, China: a retrospective study.

Jing Wang, Miao Jin, Hailong Zhang, Yanan Zhu, Hong Yang, Xiangjie Yao, Long Chen, Jun Meng, Guifang Hu, Yaqing He and 1 more

Abstract read
In one paragraph

Article in BMC infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jing Wang *Wuhan Wuchang Hospital, Wuchang Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, 430063, China.
Miao Jin *NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center Control and Prevention, Beijing, 102206, China.
Hailong ZhangShenzhen Center for Disease Control and Prevention, Shenzhen, 518055, China.
Yanan ZhuDepartment of Epidemiology, School of Public Health, Southern Medical University, Guangzhou, China.
Hong YangShenzhen Center for Disease Control and Prevention, Shenzhen, 518055, China.
Xiangjie YaoShenzhen Center for Disease Control and Prevention, Shenzhen, 518055, China.
Long ChenShenzhen Center for Disease Control and Prevention, Shenzhen, 518055, China.
Jun MengShenzhen Center for Disease Control and Prevention, Shenzhen, 518055, China.
Guifang HuDepartment of Epidemiology, School of Public Health, Southern Medical University, Guangzhou, China.
Yaqing HeShenzhen Center for Disease Control and Prevention, Shenzhen, 518055, China. heyaqing1019@126.com.ORCID http://orcid.org/0000-0001-6608-8541
Zhaojun DuanNHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center Control and Prevention, Beijing, 102206, China.

Funding

Australian Biosecurity Cooperative Research Centre for Emerging Infectious Diseases (AU) Number 6Key Project of Science and Technology 2017ZX10104001-003Study on the interaction between molecular evolution and histoblood group antigen (HBGA) of GII.2 norovirus in Shenzhen. Basic Research Project (Free-Exploration) of Shenzhen Science and Technology Innovation Committee JCYJ20170306160421143Study on the interaction between molecular evolution and histoblood group antigen (HBGA) of GII.2 norovirus in Shenzhen. Scientific Research Project of Shenzhen Municipal Commission of Health and Family Planning in 2017 SZGW2017017
6 · The paper itself

Abstract

backgroundNorovirus (NoV) is the main cause of non-bacterial acute gastroenteritis (AGE) outbreaks worldwide. From September 2015 through August 2018, 203 NoV outbreaks involving 2500 cases were reported to the Shenzhen Center for Disease Control and Prevention.

methodsFaecal specimens for 203 outbreaks were collected and epidemiological data were obtained through the AGE outbreak surveillance system in Shenzhen. Genotypes were determined by sequencing analysis. To gain a better understanding of the evolutionary characteristics of NoV in Shenzhen, molecular evolution and mutations were evaluated based on time-scale evolutionary phylogeny and amino acid mutations.

resultsA total of nine districts reported NoV outbreaks and the reported NoV outbreaks peaked from November to March. Among the 203 NoV outbreaks, 150 were sequenced successfully. Most of these outbreaks were associated with the NoV GII.2[P16] strain (45.3%, 92/203) and occurred in school settings (91.6%, 186/203). The evolutionary rates of the RdRp region and the VP1 sequence were 2.1 × 10

conclusionsThis study illustrates the molecular epidemiological patterns in Shenzhen, China, from September 2015 to August 2018 and provides evidence that the epidemic trend of GII.2[P16] recombinant strain had weakened and the non-structural proteins of the recombinant strain might have played a more significant role than VP1.

Indexed as

Caliciviridae InfectionsGastroenteritisNorovirusChinaDisease OutbreaksGenotypeHumansPhylogenyRetrospective StudiesEpidemiologyEvolutionGII.2[P16] strainNorovirusRecombinant

Identifiers

PMID34717565
PMCPMC8556823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.